AUS
NZ
UK
CA
USA
IND
Healt
A Closer Look at Cochlear Ltd (ASX:COH): Key Metrics That Shape Its Valuation
August 14, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,Key metrics offer insight into valuation and performance.,Cochlear Ltd (COH) operates from a strong financial foundation.,Innovation and global demand underpin long-term outlook.,Cochlear Ltd (ASX:COH) is part of the,ASX 200,stocks, reflec...
ASX 200 Futures Pro Medicus Records Strong Year with Major Global Contracts
August 14, 2025 03:04 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus secures multiple long-term healthcare contracts.,Cloud-native imaging solutions see increased adoption.,Pipeline expands into new medical specialties and AI.,The,ASX 200 Futures,segment has seen notable activity, with Pro Medic...
Exploring Pro Medicus Ltd (ASX:PME) in the ASX 100 Healthcare Space
August 13, 2025 05:38 PM AEST| By Team Kalkine MediaHighlights,Radiology software solutions supporting global healthcare providers,Consistent revenue streams driven by essential medical services,Expanding role of healthcare technology in diagnostic efficiency,Understanding the PME Landscape,Pro Medicu...
ASX 200 Orthocell expands Remplir rollout in United States nerve repair sector
August 13, 2025 04:43 PM AEST| By Team Kalkine MediaHighlights,Orthocell (ASX:OCC) advances Remplir adoption across multiple US hospitals,Value Assessment Committee approvals continue to progress in the US market,Distribution and logistics network strengthened to support expanding demand,ASX 200,liste...
ASX 200 small caps update: Orthocell expands US presence, Antipa adds expertise, European Lithium advances project
August 13, 2025 04:37 PM AEST| By Team Kalkine MediaHighlights,Orthocell (ASX:OCC) strengthens commercial rollout of Remplir in the United States,Antipa Minerals (ASX:AZY) appoints experienced industry professional to its board,European Lithium (ASX:EUR) engages NIRAS for Tanbreez Rare Earth Project D...
ASX 200 biotechnology company Clarity Pharmaceuticals updates clinical progress
August 13, 2025 04:24 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) secures funding to progress full clinical program,Upcoming therapeutic trial to proceed without external partnership,Upcoming data release expected to differentiate its PSMA imaging agent,ASX 200,listed Cl...
Orthocell Moves Ahead with Remplir™ Rollout in US Nerve Repair Market
August 13, 2025 10:52 AM AEST| By Team Kalkine MediaHighlights,Expansion of Remplir™ adoption in the US market,Strategic VAC approvals progressing across key hospitals,Strengthened logistics and specialist team support in place,Orthocell Ltd (ASX:OCC) is advancing its presence in the US nerve repair m...
Opyl’s AI Platform Secures Exclusive Role in Clinical Trial Risk Solutions
August 12, 2025 06:49 PM AEST| By Team Kalkine MediaHighlights,Opyl’s (OPL) TrialKey platform to act as exclusive calculation agent in global biotech insurance products,Partnership provides continuous access to diverse clinical trial data for AI model enhancement,Collaboration targets reducing trial f...
Recce Pharmaceuticals’ Innovative Topical Gel Shows Strong Burn Wound Recovery Results
August 12, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,New topical gel demonstrates strong results in infection control,Study shows improved healing rates in burn wound models,Backed by a US Department of Defense research program,Recce Pharmaceuticals Ltd (ASX:RCE) has shared new pre-clinical...
Tryptamine Strengthens Clinical Pathway with New R&D Facility Funding
August 12, 2025 04:08 PM AEST| By Team Kalkine MediaHighlights,Secures multi-million-dollar R&D loan facility,Advancing world-first Binge Eating Disorder trial,Exploring wider clinical applications for psilocin therapy,Tryptamine Therapeutics Ltd (ASX:TYP) has expanded its financial capacity through a...
Prescient Therapeutics Moves Ahead with Funding to Boost Cancer Therapy Development
August 12, 2025 11:28 AM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics progresses with latest funding round,Funds directed toward PTX-100 clinical advancements,Global trial participation continues for CTCL treatment,Prescient Therapeutics Ltd (ASX:PTX), a clinical-stage oncology company...
Anteris Technologies Advances Global Clinical Program for DurAVR® THV
August 12, 2025 11:24 AM AEST| By Team Kalkine MediaHighlights,Clinical adoption expands for DurAVR® THV,Milestone achievement with world-first dual valve procedure,Preparations progress for pivotal PARADIGM Trial,Anteris Technologies Ltd (ASX:AVR) reported steady progress in the second quarter of 202...
Imugene Extends SPP Deadline Amid Clinical Trial Progress
August 12, 2025 11:13 AM AEST| By Team Kalkine MediaHighlights,Extended SPP closing date to provide more participation time,Strong trial results for lead CAR T-cell therapy program,Expanded trial to cover new lymphoma subtypes,Imugene Ltd (ASX:IMU) has announced an extension to its Share Purchase Plan...
ASX 200 Ansell (ASX:ANN) momentum within materials and healthcare
August 11, 2025 05:43 PM AEST| By Team Kalkine MediaHighlights,Share price resilience aligns with broader sentiment despite earnings softness for (ASX:ANN),Total return benefits from distributions add to long horizon outcomes,Insider on-market activity and revenue shifts shape the narrative without al...
Noxopharm Moves HERACLES Trial Forward as Sofra Platform Expands Reach
August 11, 2025 12:35 PM AEST| By Team Kalkine MediaHighlights,HERACLES trial progresses with next dosing stage approved,Sofra platform demonstrates adaptability in immune and cancer research,Collaboration advances towards animal model studies,Noxopharm (ASX:NOX) has taken another step forward in its...
ASX:RMD Share Price: Healthcare Leader Gains Investor Attention in ASX 200
August 11, 2025 10:49 AM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) delivers innovative respiratory care solutions worldwide,Strong presence across medical devices and healthcare technology,Global operations supporting long-term growth trends,ResMed (ASX:RMD), a member of the,ASX 200,, stands...
Pro Medicus (ASX:PME) Shows Steady Growth Momentum Within the ASX 200
August 09, 2025 03:44 PM AEST| By Team Kalkine MediaHighlights,Strong track record in medical imaging software innovation,Solid financial footing with healthy balance sheet,Consistent upward revenue and profit trends,Pro Medicus (ASX:PME) is a specialist in radiology IT solutions, delivering advanced...
Exploring CSL (ASX:CSL) Shares: Insights from the ASX 200 Healthcare Sector
August 08, 2025 06:10 PM AEST| By Team Kalkine MediaHighlights,CSL operates across global healthcare segments with diverse offerings,Healthcare stocks often show resilient demand across market cycles,CSL is part of the ASX 200, reflecting its scale and significance,CSL’s Role in the Global Healthcare...
ASX 300 Percheron Therapeutics progresses with new cancer treatment developments
August 08, 2025 03:38 PM AEST| By Team Kalkine MediaHighlights,Preclinical results indicate tumour growth blockage in triple-negative breast cancer models,Activity observed as a monotherapy, broadening therapeutic scope,Plans to advance towards phase two clinical trials after phase one data release,Pe...
CSL Limited ASX 200 Faces Fresh Challenges as US Pharma Tariffs Loom
August 07, 2025 05:14 PM AEST| By Team Kalkine MediaHighlights,New US pharmaceutical tariffs threaten global supply chains and impact Australian exports,CSL Limited (ASX:CSL) may see disruptions due to blood plasma product dependency,Australian authorities monitor implications for the Pharmaceutical B...
Advertise your brand on Kalkine Media